These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
150 related articles for article (PubMed ID: 19007041)
1. Effects of verapamil on etoposide pharmacokinetics after intravenous and oral administration in rats. Piao YJ; Li X; Choi JS Eur J Drug Metab Pharmacokinet; 2008; 33(3):159-64. PubMed ID: 19007041 [TBL] [Abstract][Full Text] [Related]
2. Effects of oral curcumin on the pharmacokinetics of intravenous and oral etoposide in rats: possible role of intestinal CYP3A and P-gp inhibition by curcumin. Lee CK; Ki SH; Choi JS Biopharm Drug Dispos; 2011 May; 32(4):245-51. PubMed ID: 21506134 [TBL] [Abstract][Full Text] [Related]
3. Enhanced bioavailability of etoposide after oral or intravenous administration of etoposide with kaempferol in rats. Li C; Li X; Choi JS Arch Pharm Res; 2009 Jan; 32(1):133-8. PubMed ID: 19183886 [TBL] [Abstract][Full Text] [Related]
4. Effects of quercetin on the pharmacokinetics of Etoposide after oral or intravenous administration of etoposide in rats. Li X; Choi JS Anticancer Res; 2009 Apr; 29(4):1411-5. PubMed ID: 19414395 [TBL] [Abstract][Full Text] [Related]
5. Enhanced intestinal absorption of etoposide by self-microemulsifying drug delivery systems: roles of P-glycoprotein and cytochrome P450 3A inhibition. Zhao G; Huang J; Xue K; Si L; Li G Eur J Pharm Sci; 2013 Nov; 50(3-4):429-39. PubMed ID: 23981337 [TBL] [Abstract][Full Text] [Related]
6. Effects of morin on the pharmacokinetics of etoposide in 7,12-dimethylbenz[a]anthracene-induced mammary tumors in female Sprague-Dawley rats. Yang SH; Choi HG; Lim SJ; Lee MG; Kim SH Oncol Rep; 2013 Mar; 29(3):1215-23. PubMed ID: 23254912 [TBL] [Abstract][Full Text] [Related]
7. Effects of morin on the pharmacokinetics of etoposide in rats. Li X; Yun JK; Choi JS Biopharm Drug Dispos; 2007 Apr; 28(3):151-6. PubMed ID: 17315145 [TBL] [Abstract][Full Text] [Related]
8. Effect of P-glycoprotein inhibitor, verapamil, on oral bioavailability and pharmacokinetics of irinotecan in rats. Bansal T; Mishra G; Jaggi M; Khar RK; Talegaonkar S Eur J Pharm Sci; 2009 Mar; 36(4-5):580-90. PubMed ID: 19135530 [TBL] [Abstract][Full Text] [Related]
9. Effects of nifedipine on the pharmacokinetics of repaglinide in rats: possible role of CYP3A4 and P-glycoprotein inhibition by nifedipine. Choi JS; Choi I; Choi DH Pharmacol Rep; 2013; 65(5):1422-30. PubMed ID: 24399740 [TBL] [Abstract][Full Text] [Related]
10. Effects of quercetin on the bioavailability of doxorubicin in rats: role of CYP3A4 and P-gp inhibition by quercetin. Choi JS; Piao YJ; Kang KW Arch Pharm Res; 2011 Apr; 34(4):607-13. PubMed ID: 21544726 [TBL] [Abstract][Full Text] [Related]
11. P-glycoprotein and cytochrome P450 3A act together in restricting the oral bioavailability of paclitaxel. Hendrikx JJ; Lagas JS; Rosing H; Schellens JH; Beijnen JH; Schinkel AH Int J Cancer; 2013 May; 132(10):2439-47. PubMed ID: 23090875 [TBL] [Abstract][Full Text] [Related]
12. Influence of verapamil on the pharmacokinetics of rotundic acid in rats and its potential mechanism. Shang H; Wang Z; Ma H; Sun Y; Ci X; Gu Y; Liu C; Si D Pharm Biol; 2021 Dec; 59(1):200-208. PubMed ID: 33595422 [TBL] [Abstract][Full Text] [Related]
13. Effects of oral epigallocatechin gallate on the oral pharmacokinetics of verapamil in rats. Chung JH; Choi DH; Choi JS Biopharm Drug Dispos; 2009 Mar; 30(2):90-3. PubMed ID: 19226653 [TBL] [Abstract][Full Text] [Related]
14. Effects of the antioxidant baicalein on the pharmacokinetics of nimodipine in rats: a possible role of P-glycoprotein and CYP3A4 inhibition by baicalein. Cho YA; Choi JS; Burm JP Pharmacol Rep; 2011; 63(4):1066-73. PubMed ID: 22001996 [TBL] [Abstract][Full Text] [Related]
15. High-dose etoposide formulations do not saturate intestinal P-glycoprotein: Development, stability, and pharmacokinetics in Sprague-Dawley rats. Al-Ali AAA; Sandra L; Versweyveld D; Pijpers I; Dillen L; Vermeulen A; Snoeys J; Holm R; Nielsen CU Int J Pharm; 2020 Jun; 583():119399. PubMed ID: 32376439 [TBL] [Abstract][Full Text] [Related]
16. Effects of simvastatin on the pharmacokinetics of diltiazem and its main metabolite, desacetyldiltiazem, after oral and intravenous administration in rats: possible role of P-glycoprotein and CYP3A4 inhibition by simvastatin. Choi DH; Choi JS; Li C; Choi JS Pharmacol Rep; 2011; 63(6):1574-82. PubMed ID: 22358108 [TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetic interaction between oral lovastatin and verapamil in healthy subjects: role of P-glycoprotein inhibition by lovastatin. Choi DH; Chung JH; Choi JS Eur J Clin Pharmacol; 2010 Mar; 66(3):285-90. PubMed ID: 20012601 [TBL] [Abstract][Full Text] [Related]
18. Effect of genistein on the pharmacokinetics of paclitaxel administered orally or intravenously in rats. Li X; Choi JS Int J Pharm; 2007 Jun; 337(1-2):188-93. PubMed ID: 17267149 [TBL] [Abstract][Full Text] [Related]
19. Effects of simvastatin on the pharmacokinetics of verapamil and its main metabolite, norverapamil, in rats. Choi DH; Li C; Choi JS Eur J Drug Metab Pharmacokinet; 2009; 34(3-4):163-8. PubMed ID: 20166433 [TBL] [Abstract][Full Text] [Related]
20. Effect of hydroxyzine on the transport of etoposide in rat small intestine. Kan WM; Liu YT; Hsiao CL; Shieh CY; Kuo JH; Huang JD; Su SF Anticancer Drugs; 2001 Mar; 12(3):267-73. PubMed ID: 11290874 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]